Natco Pharma Share Price
Small Cap | Pharmaceuticals and health care | NSE: NATCOPHARM | BSE: 524816
₹796.75 -39.80 (-4.76 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 840.00
High (₹) 842.85
Low (₹) 787.25
Prev. Close (₹) 836.55
Volume 9,90,147
VWAP (₹) 770.05
ROCE (%) 28.52
Industry P/E 44.73
TTM P/E 7.65
P/B Ratio 2.44
Market Cap (₹) Cr.14,270.58
Dividend Yield (%)1.19
EPS (₹) 77.34
ROE23.65%
Sales Growth (%) 47.72
Profit Growth (%)94.09
Day Range
842.85842.85
52 Week Range
757.751,638.35
Historical Returns
Returns (6M)
-43.16 %
Returns (1Y)
-20.11 %
Returns (3Y)
-5.35 %
Returns (5Y)
40.58 %
Returns (6M)
-43.16 %
Returns (1Y)
-20.11 %
Returns (3Y)
-5.35 %
Returns (5Y)
40.58 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (97.40%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 97.40% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 23.70
MFI 9.31
ATR 65.11
Commodity Channel Index -83.84
ROC125 -48.59
ROC21 -33.67
Williams %R -97.58
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 790.05 | 809.40 | 825.90 | 773.55 | 754.20 | 737.70 | 718.35 |
Week Ago | 816.54 | 835.12 | 854.24 | 797.42 | 778.84 | 759.72 | 741.14 |
Month Ago | 1,183.06 | 1,219.78 | 1,256.31 | 1,146.53 | 1,109.81 | 1,073.28 | 1,036.56 |
EMA & SMA
796.75
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 800.70
9 Day 824.90
10 Day 831.88
12 Day 945.04
14 Day 970.94
20 Day 1036.76
26 Day 1073.05
50 Day 1200.03
100 Day 1296.80
200 Day 1293.51
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 14 Feb, 2025 | ₹891.03 | 9,71,727 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 14 Feb, 2025 | ₹890.86 | 9,71,727 | NSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹605.80 | 22,213 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹605.80 | 1,88,347 | NSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹605.80 | 22,213 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹605.80 | 1,88,347 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
27 Mar, 2025 | SANJAY NANNAPANENI | Acquisition | ₹ | 2,86,910 | NSE |
21 Mar, 2025 | VENKATA SATYA SWATHI KANTAMANI | Disposal | ₹ | 50,000 | NSE |
21 Mar, 2025 | RAJEEV NANNAPANENI | Disposal | ₹ | 50,000 | NSE |
03 Mar, 2025 | SANJAY NANNAPANENI | Acquisition | ₹ | 40,000 | NSE |
03 Mar, 2025 | SATYA VANI NANNAPANENI | Acquisition | ₹ | 4,20,000 | NSE |
31 Dec, 2024 | Lakshminarayana Bolisetty | Disposal | ₹1,391.61 | 2,000 | NSE |
31 Dec, 2024 | Venkatrao Tummala | Disposal | ₹1,380.38 | 2,500 | NSE |
21 Dec, 2024 | SADA SIVA RAO NANNAPANENI | Disposal | ₹1,467.22 | 5,000 | NSE |
02 Dec, 2024 | RAHUL TUMMALA | Disposal | ₹1,352.86 | 1,000 | NSE |
28 Nov, 2024 | RAHUL TUMMALA | Disposal | ₹1,359.24 | 900 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
12 Feb, 2025 | Rs.1.5000 per share(75%)Third Interim Dividend | 18 Feb, 2025 | 18 Feb, 2025 |
12 Nov, 2024 | Rs.1.5000 per share(75%)Second Interim Dividend (RD & XD dates revised) | 27 Nov, 2024 | 27 Nov, 2024 |
12 Aug, 2024 | Rs.3.0000 per share(150%)Interim Dividend | 23 Aug, 2024 | 23 Aug, 2024 |
Announcements
Date | Source | Detail |
---|---|---|
03 Apr, 2025 | NSE India | Natco Pharma Limited has informed the Exchange about Retirement |
03 Apr, 2025 | BSE India | Announcement under Regulation 30 (LODR) Regulations, 2015 |
03 Apr, 2025 | NSE India | NATCO PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
01 Apr, 2025 | NSE India | Natco Pharma Limited has informed the Exchange about Retirement |
31 Mar, 2025 | NSE India | NATCO PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
31 Mar, 2025 | BSE India | Disclosure under regulation 30 of the SEBI (LODR) Regulations, 2015 |
29 Mar, 2025 | NSE India | NATCO PHARMA LIMITED has informed the Exchange about Closure of Trading Window |
29 Mar, 2025 | NSE India | Natco Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
03 Mar, 2025 | BSE India | Mr. Bhimrao Dattu Jadhav has been appointed as Senior Vice President - Operations (formulations) for Pharma Division - Kothur of the Company w.e.f. 3rd March, 2025 |
03 Mar, 2025 | NSE India | NATCO PHARMA LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results & Interim Dividend | -- | 31 Jan, 2025 | 12 Feb, 2025 |
Quarterly Results & Interim Dividend | -- | 29 Oct, 2024 | 12 Nov, 2024 |
Quarterly Results & Interim Dividend | -- | 29 Jul, 2024 | 12 Aug, 2024 |
Audited Results | -- | 10 May, 2024 | 27 May, 2024 |
Quarterly Results & Interim Dividend | -- | 05 Feb, 2024 | 14 Feb, 2024 |
Quarterly Results & Interim Dividend | -- | 06 Nov, 2023 | 14 Nov, 2023 |
Quarterly Results & Interim Dividend | -- | 02 Aug, 2023 | 09 Aug, 2023 |
Audited Results | -- | 22 May, 2023 | 29 May, 2023 |
Buy Back of shares | -- | 10 Mar, 2023 | 08 Mar, 2023 |
Quarterly Results & Interim Dividend | -- | 01 Feb, 2023 | 09 Feb, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 49.62% | 49.71% | 48.82% | 48.86% | 48.91% |
Foreign Institutions + | 17.94% | 13.72% | 11.73% | 12.23% | 18.16% |
Domestic Institutions + | 5.59% | 11.26% | 14.93% | 18.11% | 15.04% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 26.85% | 25.31% | 24.52% | 20.8% | 17.89% |
Others | 0% | 0% | 0% | 0% | 0% |
About Natco Pharma
Natco Pharma is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1981PLC003201 and registration number is 003201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3568.90 Cr. and Equity Capital is Rs. 35.80 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1981
Managing Director
-- --
NSE Symbol
NATCOPHARM
Natco Pharma Management
Name | Designation |
---|---|
Mr. V C Nannapaneni | Chairman & Ind.Director |
Mr. Rajeev Nannapaneni | Director & CEO |
Mr. P S R K Prasad | Director & Exe. VP (Corp. Engg. Services) |
Dr. D Linga Rao | Director & President (Tech. Affairs) |
Dr. Pavan Ganapati Bhat | Director |
Mr. D Vijaya Bhaskar | Independent Director |
Mr. A D M Chavali | Independent Director |
Dr. Kantipudi Suma | Addnl. & Ind.Director |
Mr. Nitin Jain | Addnl. & Ind.Director |
Mr. Lakshminarayana Bolisetty | Addnl. & Ind.Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Natco Pharma
What is the share price of Natco Pharma?
The share price of Natco Pharma on 04 Apr, 2025 is ₹ 796.75.
What is 52W high and 52W low share price of Natco Pharma?
The highest and lowest 52W share prices of Natco Pharma are ₹ 1638.350 and ₹ 757.750
What is the market cap of Natco Pharma?
The market capitalization of Natco Pharma as of 04 Apr, 2025 is ₹ 14,270.58 Crores
What is the P/E ratio of Natco Pharma?
The current P/E ratio of Natco Pharma as of 04 Apr, 2025 is 44.73
What is the PB ratio of Natco Pharma?
The PB ratio of Natco Pharma as of 04 Apr, 2025 is 2.44
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)